4//SEC Filing
Harmon Cyrus 4
Accession 0001415889-25-017234
CIK 0001750284other
Filed
Jun 12, 8:00 PM ET
Accepted
Jun 13, 5:00 PM ET
Size
5.7 KB
Accession
0001415889-25-017234
Insider Transaction Report
Form 4
Harmon Cyrus
Director
Transactions
- Award
Stock Option (right to buy)
2025-06-11+24,150→ 24,150 totalExercise: $4.08Exp: 2035-06-11→ Common Stock (24,150 underlying)
Footnotes (1)
- [F1]The shares subject to the option vest in a series of 12 successive equal monthly installments measured from June 11, 2025, subject to the Reporting Person's continuous service through each applicable vesting date. Such shares vest in full on the date of the Issuer's next annual meeting of stockholders if such stock option is not otherwise fully vested by such date, subject to the Reporting Person's continuous service through such vesting date.
Documents
Issuer
Olema Pharmaceuticals, Inc.
CIK 0001750284
Entity typeother
Related Parties
1- filerCIK 0001831410
Filing Metadata
- Form type
- 4
- Filed
- Jun 12, 8:00 PM ET
- Accepted
- Jun 13, 5:00 PM ET
- Size
- 5.7 KB